AbCellera Biologics Inc. (ABCL)
$12.64+0.72%Close
BUYCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.9B
- Beta
- 1.19
- P/E (TTM)
- -24.35
- Short % float
- 15.85%
- Days to cover
- 6.0
- SI change
- -4.2%
- 1W
- -8.27%
- 1M
- +16.07%
- vs SPY 1W
- -8.69%
- vs SPY 1M
- +14.01%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ABCL?
- LOPJLB’s latest quantitative signal on AbCellera Biologics Inc. (ABCL) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is ABCL in?
- AbCellera Biologics Inc. (ABCL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does AbCellera Biologics Inc. (ABCL) do?
- AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or un…